稳健医疗2024年半年度报告（英文版）

2024 Semiannual Report Brand Ambassador of Purcotton Guo Jingjing Winner Medical Co., Ltd. Semi-Annual Report Stock code: 300888 Brand Ambassador of Purcotton Guo Jingjing Important Notes, Contents, and Definitions 2024 Semiannual Report 3 Section Ⅰ Important Notes, Contents, and Definitions The Board of Directors, the Board of Supervisors and directors, supervisors and senior management of Winner Medical hereby guarantee that the statement in this Semi-annual Report is authentic, accurate and complete without false or misleading information or material omission and will assume all the legal liabilities, individually and jointly. Li Jianquan, the head of the Company, Fang Xiuyuan, the head of accounting work, and Zhao Yan, the head of accounting body (accounting manager), guarantee the authenticity, accuracy, and completeness of the financial report in this semi-annual report. All directors of the Company have personally attended the board meeting for reviewing this semi-annual report. The forward-looking contents in this semi-annual report, such as the future development strategy and performance planning, are the goals set by the Company, which are planned matters. The achievement of the goals depends on many factors, including unexpected market change. So these contents are not the Company’s profit forecast for the next year, or shall it constitute a substantial commitment of the Company to investors and related parties. Investors and related parties should be fully aware of related risks and understand the differences among plans, forecasts, and commitments. Investors are asked to beware of investment risks! The planned profit distribution deliberated and approved by the board of directors is as follows: taking 582,329,808 as the radix, the Company will distribute cash dividends of 4.00 yuan (tax included) and 0 bonus share (tax included) to all shareholders for every 10 shares, and no capital reserve will be conversed to share capital. 4 Contents Section Ⅰ Important Notes, Contents, and Definitions ................................................................................................................ 3 Section Ⅱ Company Profile and Major Financial Indicators ...................................................................................................... 8 Section Ⅲ Management Discussion and Analysis ................................................................................................................... 13 Section Ⅳ Corporate Governance ............................................................................................................................................ 53 Section V Environmental Protection and Social Responsibility ............................................................................................... 58 Section VI Important Matters .................................................................................................................................................